Digital therapeutics company Twill, previously known as Happify Health, is partnering with e-Psychiatry to offer virtual access to psychiatrists, psychologists and therapists.
Conn.-based e-Psychiatry's services will be offered as an element of Twill's Sequences, a platform made up of digital therapeutics, community groups and coaching aimed at mental health conditions and pregnancy.
Twill is...
Digital therapeutic company Happify Health has announced several partnerships this year, including a collaboration with insurer Elevance Health, formerly Anthem, on maternal health and an agreement with pharma company Biogen aimed at multiple sclerosis patients.
Chris Wasden, Happify's chief strategy officer, says these partnerships add access points for patients who could use their products. He...
Digital therapeutic maker Happify Health is partnering with neuroscience-focused pharma company Biogen on a digital engagement and education platform for multiple sclerosis.
The product will include Happify's community for people living with MS, as well as access to neurology providers like doctors and nurses, mental health professionals, dietitians and rehabilitation professionals. Biogen will...
Happify Health announced Monday it has entered into an agreement with healthcare services and pharmaceutical company Zuellig Pharma to commercialize two of its prescription digital therapeutics in Asia.
The deal includes Ensemble, Happify's therapeutic for treating major depressive disorder and generalized anxiety disorder, and a prescription digital therapeutic for chronic insomnia. The PDTs...
Digital therapeutics are a growing field in the larger digital health space, but they’re still relatively new. What’s the state of the market, and how can the companies behind these products encourage their uptake?
With regard to mental and behavioral health – a clinical area that’s ripe for digital health investment – many people who have mental illnesses don’t receive care. The scalability of...
Direct-to-consumer virtual health company Hims & Hers Health announced its plans to grow its Medical Advisory Board from five members to 15 members. The new members come from an array of medical specialties including urology, mental health and infectious disease.
This news comes roughly a year after the company went public through a SPAC merger. Since listing on the New York Stock Exchange,...
Happify Health is launching its first prescription digital therapeutic (PDTx), called Ensemble, which will focus on treating Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD).
Unlike Happify’s other products, Ensemble has to be prescribed by a clinician. Patients are able to use the smartphone or computer in order to tap into the therapeutic. The PDTx is focused on helping...
Happify Health, a platform for mental health and disease management programs, has brought in $73 million in funding as part of a new Series D and other "related financing." Deerfield Management Company headed the investments, which also included funds from Omega Capital Partners, ION Crossover Partners and other prior backers.
WHAT IT DOES
Founded in 2012, Happify is best known for digital...
The digital health ecosystem has swelled to encompass a broad range of products over the years.
On one end of the spectrum is software-as-medical-devices (SaMD) and prescription digital therapeutics, product categories for which a comprehensive regulatory strategy and engagement with the FDA are mandatory. On the other are wellness apps and other low-risk digital tools that likely spend more time...
A call for independent policing of non-HIPAA health data. The Center for Democracy & Technology, a nonprofit organization focused on tech policy and architecture, and the eHealth Initiative & Foundation, a coalition of industry and academic stakeholders, yesterday released a framework proposal calling for self-regulation of consumer data use by health devices and products that don't...
